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Amputation Pain Management
Melinda S. Seering and Sangini Punia
Abstract
Considerable number of new amputations yearly in the United States and 
internationally represent considerable population experiencing pain that is not just 
acutely from surgical insult but chronically that is related to phantom limb pain and 
residual limb pain. This chronic pain can last from weeks to years in these patients 
and lead to other debilitation such as depression, anxiety and even opioid addiction. 
Early interventions help lessen long-term pain for these patients. These interven-
tions include nerve blockade as well as multi-modal therapy. Understanding the 
pathophysiology of the pain experienced by these patients will better allow any 
provider to care for these patients effectively and help alleviate chronic pain in the 
long term.
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1. Introduction
Patients with amputations can be found living fulfilled lives. We have all seen 
them running marathons, in the Olympics, surfing, climbing Mount Everest and 
even as an MLB pitcher. However, most just want to lead normal lives and be the 
best parents, siblings, friends, or co-workers they can be. They want to return 
to their job and function in their daily lives as they did before. Recovery from an 
amputation is not immediate and takes significant time. Recovery time from ampu-
tation is usually prolonged. Wound healing is done in 4–8 weeks, but the prolonged 
mental, emotional, and physical recovery afterwards takes much longer and will be 
different for everyone. One of the limiting factors for recovery from an amputation 
is pain.
In looking at data from the Amputee Coalition, there are 185,000 in the United 
States every year. This means that an average of two million people is living with an 
amputated extremity in the United States alone [ 1–3]. Other data to consider is just 
as alarming; globally, there are 1 million amputations annually. This is an estimated 
1–2 amputation per minute. Lower limb amputations are the most common, with 
most being due to vascular disease. 85% of lower limb amputations are preceded 
by a foot ulcer. About half of the people with diabetes who get a lower limb ampu-
tation will receive a second amputation [4]. African American populations are 
four times more likely to get an amputation than Caucasian [5]. Around a third of 
these patients have persistent depression and anxiety after their amputation [6]. 
Financially, it is noted that amputees have higher healthcare costs and if the ampu-
tation was related to vascular disease higher mortality [7].
All these factors can lead to an unknown fear for a patient undergoing an 
amputation. Understanding the cause of an amputation first is paramount. This 
can help guide a plan for better pain control in the perioperative period. The main 
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causes of amputation are progression of disease processes such as peripheral 
vascular disease (82%) including ischemia and thrombosis. Diabetes and infec-
tions such as osteomyelitis and gangrene that is unresponsive to antibiotic treat-
ment. The second major cause is trauma (16.4%). This has a high predominance 
in upper extremity amputations. Lower extremity amputations with trauma can 
also be seen with severe fractures that do not heal and frost bites as other causes. 
Finally, surgical removal of malignancies (0.9%) can result in amputations in 
upper or lower extremities depending on the location and type of the tumor and 
growth. Congenital malformations (0.8%) make up the final list for amputation 
categories [1, 2].
It is important as we consider the cause of the amputation and perioperative 
pain control, we also factor in the amount of time each patient had before surgery 
for their amputation decision. A diabetic patient that had a long time to make a 
decision for an amputation may have had considerable time to go through the stages 
of grief and accept the amputation as opposed to a trauma that did not have this 
time. Other things to consider are support system that the patient has at home. As 
discussed, wound healing is brief, but psychological healing will take longer in 
most and require repeated support and reminders to the patient to keep moving in a 
positive direction [8]. In addition to medical management, these patients will need 
pain-coping strategies and too many these may be a new technique for them in a life 
altering situation.
2. Pain classification with an emphasis on amputees
Amputation patients have a variety of different pain to consider when treating 
them in the perioperative setting. The broad classification of this pain is post-
amputation pain. However, further classifying it in four categories helps to better 
understand each pain and how it originates. They are acute post-operative pain, 
phantom sensations, residual limb pain and phantom limb pain [2, 3].
Acute post-operative pain is the pain that most surgical patients experience after 
any surgery. It is the pain at the surgical incision site related to surgical trauma, 
swelling and tissue damage. This is usually reported as sharp and stabbing by 
patients due to nociceptive afferent nerve supply at the surgical site. Patient can 
also report muscle spasms related to the immobility of the limb or the compression 
dressing or brace applies to the amputation site after surgery [2, 9, 10].
Phantom sensations are the non-painful sensations arising from the amputated 
extremity. This is reported by 75% of patients 4 days after the amputations and 
higher at 6 months. This can be perceived as movement of the prior extremity or 
portion of the extremity (i.e. toe or finger). The patient can also note tempera-
ture changes or position changes or the missing limb. This has also been noted in 
mastectomies, dental extractions, and enucleations as well, and can also be seen 
in spinal cord injuries. Many of the phantom sensations are mild and decline but 
some patients have some degree persistent sensations indefinitely. There are a few 
patients in whom these sensations progress to severe pain and become problematic, 
leading to residual limb pain or phantom limb pain. There are reports of phantom 
sensations that do fade away and they appear to do this in a progressive fashion 
called telescoping. This is most common in upper extremity amputations where the 
phantom sensations continue to decrease such that eventually the patient is left with 
a sensation of the hand on the stump alone instead of distal [ 2].
Residual limb pain (stump pain) is the pain localized to the remained affected 
body segment and can be present for years. Residual limb pain can be of many 
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different modalities as it can be described as deep tissue pain, superficial incision 
pain and neuropathic in nature. 75% of patients will experience a component of 
this chronically after surgery [11]. Neuropathic pain will be described as burning 
and electric in nature. Some patient may even become hyperalgesia or have allo-
dynia on the stump site. This may lead to difficulty with prosthetic fitting for the 
patient. This pain is usually noted early in recovery. There are causes of increased 
stump pain: infection, stump neuroma, heterotopic ossification [9]. These should 
be assessed with prolonged or increased stump pain as these are easily treatable. 
Infection is not uncommon in these patients due to high prevalence of diabetes and 
peripheral vascular disease. This should be assessed and treated with antibiotics 
accordingly to prevent sepsis and wound dehiscence. Stump neuromas occur when 
the severed nerve at the amputation site have an inflammatory mediated immune 
reaction. This can cause pain, but it can also cause unmyelinated A and C fibers to 
form around the nerve. Neuromas develop over time and usually are characterized 
by point pain on the stump and sensory changes. Heterotopic ossifications usually 
occur later after amputation as well. These are calcium deposits that occur in the 
soft tissue of the stump. These ossifications occur much higher in traumatic ampu-
tations. There is some association with traumatic brain injury and the risk of this 
occurrence as well [2, 3, 12].
Phantom limb pain was first described in 1462 by French Surgeon, Ambrose 
Pare’ [13]. However, it was not until 1871 that Silas Weir Mitchell, a Civil War 
surgeon, called this phenomenon “phantom limb” [2, 13]. Phantom limb pain is an 
unpleasant or painful feeling in the amputated extremity. 45–85% of patients from 
amputations can suffer from phantom limb pain [ 9]. This can have neuropathic 
components with burning and electrical shooting pain and nociceptive components 
of dull, aching, crushing and cramping pain [13]. There are two times of onset for 
this pain. One is usually early after amputation in the first month and the second 
can occur a year after amputation. The further out a patient is from amputation the 
less likely they will experience this. However, if a patient does begin to experience 
this, it can last for years. Phantom limb pain does not always have to occur alone and 
usually occurs with residual limb pain. While residual limb pain may be bothersome 
early on, phantom limb pain persists and become more bothersome later and tends 
to last longer. Risk factors for development or prolonging phantom limb pain are 
found in Table 1 [1–3, 12, 13].
1. Female gender
2. Elevated pre-amputation pain
3. Upper extremity
4. Increasing age
5. Bilateral amputation
6. Traumatic amputation
7. Stump healing
8. Disease states such as fibromyalgia, migraines, Raynaud’s, IBS, irritable bladder, depression, and anxiety
9. Poor social support
10. High expectations
11. Poor coping strategies
Table 1. 
Risk factors for developing or prolonged phantom limb pain.
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3. Pain signal transmission
To understand how to treat the pain from amputations, we should first take a 
moment to review how painful stimulation is transmitted through the body (see 
Figure 1). The human body receives signals from various inputs. If something 
painful happens to the body such as surgical insult, the damage is registered by 
nociceptors in the periphery. The distal nerve fibers coalesce and become peripheral 
nerves. There are pain receptors that present on the neuron and it is connected by 
an axon to the spinal cord. Transmission from peripheral nerve to dorsal column 
is obtained by different nerve fibers. These include: A-alpha fibers, the A-beta 
fibers, the A-delta fibers, and the C fibers. Pain travels on two different nerve 
fibers: A-delta and C-fibers. A-delta fibers are large myelinated fibers that carry 
sharp pain, whereas C-fibers are small and unmyelinated fibers that produce dull, 
slow spreading pain. This signal arrives to the dorsal horn and then travels up via 
neurotransmitters to the brain. There are a variety of neurotransmitters from the 
spinal cord to the thalamus. For pain, the most important to consider are Substance 
P which is an excitatory neurotransmitter for second order neurons in the dorsal 
horn. This neurotransmitter has been shown to sensitize nociceptors. In addition 
to pain, Substance P also related to inflammation, cell growth, vasodilation and 
even mood regulation. Glutamate is also a primary neurotransmitter for pain. It is 
the main excitatory neurotransmitter in the body. In the brain, glutamate receptors 
can be both pro-nociceptive as well as anti-nociceptive. This leads to many pain 
therapies constructed at glutamate. This is used for central sensitization in chronic 
pain patients [14]. Once in the dorsal horn, the second order neurons connect with 
thalamus and other various areas. These can include the somatosensory cortex 
(physical sensation), limbic system (emotion) and frontal cortex (upper level 
thinking). This allows a patient to feel and react with pain not just physically but 
emotionally as well [15].
Figure 1. 
Path pathways.
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Let us revisit how the various pain pathways are affected during amputation. 
Phantom pain sensations likely result from changes in the somatosensory cortex. 
This causes afferent nociceptive stimulation from body parts near the amputation 
sites (such as face for upper extremity amputation or bladder for lower extremity 
amputation). Due to this reorganization in the somatosensory cortex and stimula-
tion input, the phantom sensations occur [2, 9].
Peripheral nerves likely play a large role in the phantom limb pain and residual 
limb pain. Damage to distal nerve endings and axons causes inflammation and 
alteration in neurotransmission along the usual pain pathway. The distal nerve 
endings will begin to regenerate but there will be non-functional axons, changes in 
sodium and potassium channels and different input from the spinal cord. Neuromas 
can form here as discussed previously. This can also result in higher pain due to 
more catecholamines in circulation due to increased sympathetic discharge [2, 9].
There are also spinal cord changes in the dorsal horn related to pain after 
amputation. The peripheral nerves are no longer able to send the usual signals along 
the axons to the spinal cord. The brainstem reticular areas therefore do not send 
inhibitory sensory transmission, so the dorsal horn receives input from this body 
part as high sensory feedback resulting in pain transmission [1, 2, 9].
These changes in the peripheral and spinal cord need to be considered as we are 
thinking about treating each patient for amputation pain.
4. Protocol for perioperative caring for amputation patients
It is well understood that effective control of acute post-amputation pain 
results in decreased risk of development of residual and phantom limb pain [16]. 
Perioperative plans need to set up within a multi-disciplinary team, ideally involving 
surgeon, anesthesia, in-patient acute pain teams, pharmacy, physical therapy, occu-
pational therapy, nutrition, and social work to name a few. The pre-operative optimi-
zation is essential to control of acute post-amputation pain and help decrease the risk 
of development of chronic and phantom pain to help these amputation patients have 
the best chance for better pain control post-amputation. Thorough pre-operative 
evaluation is needed to look at co-medical conditions that can be optimized. The 
patient’s nutrition should be optimized for wound healing as well. Physical therapy 
and occupational therapy should work with the patient before surgery to improve 
physical status prior to surgery and make post-operative recovery more successful. 
Patient should have a pre-operative discussion about post-operative pain manage-
ment and expectations. This will allow goal setting and help with anxiety the patient 
may be experiencing.
Patients who struggle with high pain scores prior to amputation may have 
an elevated risk of developing chronic pain [17]. Thus, aggressive multimodal 
analgesic therapy instituted pre-operatively and early in the post-operative period 
could be beneficial in reducing the incidence of chronic pain. One study found that 
the presence of depressive symptoms was also a predictor of increased intensity 
of chronic pain in amputees [18]. Thus, it may be worthwhile to address these 
symptoms prior to elective amputation surgery. Patients with a complex history of 
chronic pain disorders and/or patients having high baseline daily opioid require-
ments (> 80 mg oral morphine equivalents) should be further selected to undergo a 
pre-operative appointment with a pain specialist. This appointment should ideally 
take place around 4 weeks prior to elective amputation with the goal to optimize the 
patient’s pain regimen pre-operatively, by maximizing non-opioid modalities and 
reduction of daily opioid consumption if possible. This is done to improve response 
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to opioid therapy in the immediate post-operative period. Thorough patient 
education and compassionate counseling also play a key role in developing a team 
relationship with the patient [19, 20]. See Figure 2 for full protocol.
5. Nerve blockade
The current standard of care is pre-operative nerve blockade to prevent peripheral 
sensitization leading to future onset of phantom limb pain. Successful outcomes 
necessitate effective communication between the surgeon, anesthesiologist, and the 
various teams involved in the post-operative rehabilitation of the patient. A consulta-
tion with the Acute Pain Service or similar entity that performs peripheral nerve 
blockade pre-operatively and then follows the patient during their post-operative 
inpatient course is an important factor in the success in early prevention of acute and 
chronic pain for these patients.
Most patients that arrive for amputations should be evaluated to receive pre-
operative peripheral nerve blocks. If this cannot be done pre-operatively, patients 
can be evaluated post-operatively for a nerve block. If patients do not require 
post-operative anti-coagulation that will preclude a continuous peripheral nerve 
catheter, this would be the preferred nerve block for these patients as this will help 
with prevention phantom limb pain and chronic post-operative pain [3]. This can 
be utilized for 3–5 days. Continuous nerve catheter infusions have been found to 
decrease post-operative morphine requirements [21]. However, in addition, there 
are other factors that may preclude continuous peripheral nerve catheter placement 
such as infection, and patient factors. If this is the case, single shot peripheral nerve 
blocks may be utilized. Interestingly, a systematic review and meta-analysis found 
no difference in pain scores at 24 hours between patients that received a nerve block 
and those that did not [22]. However, this study did not look at chronic pain in these 
patients which is the important component that these nerve blocks are used for [9].
It is important to understand the anatomy of the amputation site to have successful 
nerve block placement. For example, a below the knee amputation will rely heavily 
on a sciatic nerve blockade whereas an above the knee amputation will need blockade 
of both femoral and sciatic nerves for successful pain control and help with periph-
eral sensitization for the patient [9]. For upper extremity amputations, a forearm 
Figure 2. 
Protocol for amputation pain management.
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amputation will be lower in the brachial plexus than an above the elbow amputation 
or shoulder disarticulation. Tourniquet site is also paramount when planning periph-
eral nerve block placement. If the catheter is in the surgical site or tourniquet site, 
there is a risk for dislodgement. It is important to remember this with placement and 
keep the securement of catheter out of the surgical field. This will take good commu-
nication between anesthesia provider and surgeon to achieve this effectively.
It should be noted that epidural blockade may also be used for lower extremity 
amputation, especially if it will be a bilateral lower extremity amputation. There are 
studies that show pre-operative epidural placement in amputation patients prevent 
phantom limb pain due to stopping nociceptive input to the spinal cord [ 3]. There 
is no comparison of epidural to peripheral nerve catheters for lower extremity 
amputations, but on a practically note, peripheral nerve blockade will allow better 
mobilization and participation in physical therapy [3]. In addition, peripheral nerve 
block does not have the hemodynamic affects that epidural blockade can have [23].
6. Pharmacology
6.1 Opioids
Opioids remain a favored therapy for pain after surgery. They bind to Mu 
receptors in peripheral and central nerves as an agonist fashion to produce anal-
gesia. They also can affect phantom limb pain by reducing cortical reorganization 
[10]. There is a wide variety to choose from post-operatively as they come in 
intravenous and oral formulation. Usually initially a parenteral opioid therapy 
with a patient-controlled analgesia (PCA) is started on post-operative day (POD) 
zero. Once the patient is tolerating a diet, the PCA is weaned down incrementally 
and oral opioid therapy is instituted. For opioid tolerant patients, we attempt to 
calculate their total daily morphine equivalent requirement and base our starting 
oral dose based on that. The goal is to wean off the PCA completely by 48 hours, 
coinciding with the discontinuation of other intravenous infusion [10].
6.2 N-Methyl-D-Aspartate (NMDA) Receptor Antagonists
Ketamine has been studied for post-operative pain. It has been shown that the 
use of this medication lowers the opioid requirements and reverses opioid tolerance 
needed for acute post-operative pain [ 24]. Ketamine is a noncompetitive NMDA 
receptor antagonist that targets primarily in the brain and spinal cord. The NMDA 
receptor is important for synaptic plasticity, central sensitization, amplification of 
pain signals and opioid tolerance. For amputations, it lowers the dorsal horn sensi-
tization and stops the events that may lead to phantom limb pain and residual limb 
pain. Important to note, it will not prevent phantom limb pain but will reduce risks 
of phantom limb pain and residual limb pain [9]. Ketamine has also been shown to 
have anti-inflammatory properties which may be effective in the early pre-operative 
phase. Ketamine infusions can be started in the operating room and continued for 
2–3 days post-operatively. Studies show low does ketamine infusions do reduce 
opioids immediately post-op but there was not a significant reduction in immediate 
post op pain ratings [2, 3, 10].
6.3 Gabapentinoids
Gabapentin and pregabalin are both anti-convulsant that inhibit alpha 2-delta 
subunit of voltage-gated calcium channels. They are structural like GABA 
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neurotransmitter, but they are unable to bind to any GABA receptors. In addition 
to the use with seizures, it has been used for chronic pain, especially neuropathic 
in nature. Dosages must be titrated slowly, and results are not seen immediately. 
These doses also must be adjusted for patients with impaired renal function with 
the help of a pharmacist [25, 26]. However, some studies claim that its efficacy to 
treat phantom limb pain is inconclusive and limited by dose dependent side effects 
like somnolence and dizziness [2]. There are other studies more recently that show 
promise of administration of gabapentinoids for reducing chronic post-surgical 
pain and this can be exploited to amputees as well [3, 9, 10].
6.4 Acetaminophen
Acetaminophen’s exact mechanism of action is not well understood, but it is 
thought to reduce the production of prostaglandins in the brain. Prostaglandins 
are chemicals that cause inflammation and swelling. Acetaminophen relieves pain 
by elevating the pain threshold, that is, by requiring a greater amount of pain to 
develop before a person feels it. Acetaminophen administration to amputation 
patients will help with inflammation and an adjunct to help with post-surgical 
nociceptive pain, which has been shown to decrease opioid requirements. 
Acetaminophen dosages will be lowered in patients with pre-existing liver disease 
[27]. This will be the most beneficial in the early pre-operative phase. It may be 
especially beneficially to start prior to the amputation as part of a pre-emptive 
analgesia. This is thought to protect the central nervous system from noxious insults 
which result in the patient getting hyperalgesia and allodynia [10, 28].
6.5 NSAIDs
NSAIDs work by inhibiting the activity of cyclooxygenase enzymes (COX-1 or 
COX-2). By blocking the Cox enzymes, many prostaglandins are not made. This 
means that there is less swelling and less pain. Most NSAIDs block both Cox-1 and 
Cox-2 enzymes. For pain, this specifically looks at enzymes that work with prosta-
glandins for inflammation. Like acetaminophen, these medications work well in the 
acute perioperative phase for nociceptive pain and reducing opioid requirements. 
Their use can be limited due to post-operative bleeding concerns. Usually these 
medications do not help with chronic post amputation pain or phantom limb pain. 
A short course may be suitable for some patients that have normal renal function; 
however, we do not advocate for chronic NSAID therapy due to the risks of gastroin-
testinal bleeding and renal toxicity [10, 23, 29].
6.6 Muscle relaxants
As discussed earlier, acute post-operative pain can have spasmodic pain proximal 
to the stump site, likely due to tissue inflammation. This can also be present with 
residual limb pain in some patients. There are a variety of muscle relaxants that 
can be tried for a short period of time [30]. If the patient is on opioids, would be 
cautious of adding a benzodiazepine for muscle relaxant. There is a lack of adequate 
literature supporting the use of muscle relaxants for post amputation pain.
6.7 Tri-cyclic antidepressants and selective norepinephrine reuptake inhibitors
Anti-depressants are commonly prescribed for chronic neuropathic pain and 
coexisting depression that accompanies it. These medications work by inhibiting 
serotonin-epinephrine uptake blockade, NMDA receptor antagonism and sodium 
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channel blockade. These medications have not been shown to work effectively 
in phantom limb pain in studies. These are not usually done in the perioperative 
setting as they require careful titration over weeks to months which is better done as 
outpatient therapy. Side effects of opioids and other modalities may warrant a small 
dose trial in the perioperative setting to help with uncontrolled acute or phantom 
limb pain [9, 10, 31].
6.8 Calcitonin
Calcitonin is a hormone secreted by thyroid gland in parafollicular cells. Unlike 
the parathyroid hormone, its job is to reduce calcium in the blood. There are 
synthetic forms of this used for chronic pain syndromes. The exact pain mechanism 
of action is unknown. There are mixed results of phantom limb pain [10]. The 
greatest benefit has been shown when it is administered early in the perioperative 
period; usually within the first 7 days [32]. There are reports of complete resolution 
of phantom limb pain with its use [9].
7. Therapeutic modalities
There are many additional modalities that may be of benefit to amputee patients 
after the initial perioperative period to help with phantom limb pain and residual limb 
pain. Many of these involve experienced providers and therapists [2, 10, 12, 33–36]. 
These are summarized in Table 2.
8. Conclusions
As patient’s present for amputations, it is important to remember the care for 
these patients needs to be multi-disciplinary to prevent chronic pain. If periopera-
tive pain plans are developed early and worked on as a team, the patient will benefit 
the most and have the best chance for success at not having long-term phantom 
limb pain and/or residual limb pain which adversely impact their quality of life. 
1. Desensitization techniques
2. Mirror therapy
3. Massage
4. TENs
5. Exercise
6. Hot/cold therapy
7. Biofeedback
8. Peripheral nerve stimulation
9. Prolonged peripheral nerve blockade
10. Sympathetic nerve blocks
11. Deep brain stimulators
12. Spinal cord stimulators
13. Neurolysis
Table 2. 
Therapeutic modalities for chronic amputee limb pain.
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Psychological preparation is paramount but may not always be accomplished if 
amputation is needed in emergent or traumatic fashion. These patients can still 
be cared for effectively in a modified format with high success rate if early post-
operative intervention is achieved.
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